ArticleDiabetes2020

In Vivo Reporter Assays Uncover Changes in Enhancer Activity Caused by Type 2 Diabetes-Associated Single Nucleotide Polymorphisms.

Ana Eufrásio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.